Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $89.6500 (-2.16%) ($89.4800 - $91.4100) on Thu. Sep. 10, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.39% (three month average) | RSI | 33 | Latest Price | $89.6500(-2.16%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -0.9% a day on average for past five trading days. | Weekly Trend | ABBV declines -2% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(50%) SPLV(39%) VYM(36%) DIA(35%) IVE(34%) | Factors Impacting ABBV price | ABBV will decline at least -0.695% in a week (0% probabilities). VIXM(-25%) UUP(-9%) VXX(-6%) IGOV(-5%) TLT(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.695% (StdDev 1.39%) | Hourly BBV | -1.3 () | Intraday Trend | -1.1% | | | |
|
Resistance Level | $93.72 | 5 Day Moving Average | $91.05(-1.54%) | 10 Day Moving Average | $92.47(-3.05%) | 20 Day Moving Average | $93.72(-4.34%) | To recent high | -11.1% | To recent low | 0% | Market Cap | $158.168b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |